JP2009507474A5 - - Google Patents

Download PDF

Info

Publication number
JP2009507474A5
JP2009507474A5 JP2008527463A JP2008527463A JP2009507474A5 JP 2009507474 A5 JP2009507474 A5 JP 2009507474A5 JP 2008527463 A JP2008527463 A JP 2008527463A JP 2008527463 A JP2008527463 A JP 2008527463A JP 2009507474 A5 JP2009507474 A5 JP 2009507474A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
acid sequence
polypeptide according
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008527463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009507474A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/065561 external-priority patent/WO2007023163A1/en
Publication of JP2009507474A publication Critical patent/JP2009507474A/ja
Publication of JP2009507474A5 publication Critical patent/JP2009507474A5/ja
Withdrawn legal-status Critical Current

Links

JP2008527463A 2005-08-26 2006-08-22 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド Withdrawn JP2009507474A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501190 2005-08-26
PCT/EP2006/065561 WO2007023163A1 (en) 2005-08-26 2006-08-22 Polypeptides having antimicrobial activity and polynucleotides encoding same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012278182A Division JP2013100301A (ja) 2005-08-26 2012-12-20 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド

Publications (2)

Publication Number Publication Date
JP2009507474A JP2009507474A (ja) 2009-02-26
JP2009507474A5 true JP2009507474A5 (cg-RX-API-DMAC7.html) 2009-08-27

Family

ID=37056517

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008527463A Withdrawn JP2009507474A (ja) 2005-08-26 2006-08-22 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド
JP2012278182A Pending JP2013100301A (ja) 2005-08-26 2012-12-20 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012278182A Pending JP2013100301A (ja) 2005-08-26 2012-12-20 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド

Country Status (28)

Country Link
US (1) US7745576B2 (cg-RX-API-DMAC7.html)
EP (1) EP1922333B1 (cg-RX-API-DMAC7.html)
JP (2) JP2009507474A (cg-RX-API-DMAC7.html)
KR (1) KR101362710B1 (cg-RX-API-DMAC7.html)
CN (2) CN102643337A (cg-RX-API-DMAC7.html)
AP (1) AP2008004415A0 (cg-RX-API-DMAC7.html)
AR (1) AR055394A1 (cg-RX-API-DMAC7.html)
AT (1) ATE462720T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006283904B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614968A2 (cg-RX-API-DMAC7.html)
CA (1) CA2620125C (cg-RX-API-DMAC7.html)
CY (1) CY1110024T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006013330D1 (cg-RX-API-DMAC7.html)
DK (1) DK1922333T3 (cg-RX-API-DMAC7.html)
ES (1) ES2343586T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20100340T1 (cg-RX-API-DMAC7.html)
IL (1) IL189135A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008002485A (cg-RX-API-DMAC7.html)
NO (1) NO20081470L (cg-RX-API-DMAC7.html)
NZ (1) NZ565926A (cg-RX-API-DMAC7.html)
PL (1) PL1922333T3 (cg-RX-API-DMAC7.html)
PT (1) PT1922333E (cg-RX-API-DMAC7.html)
RS (1) RS51325B (cg-RX-API-DMAC7.html)
RU (1) RU2512525C2 (cg-RX-API-DMAC7.html)
SI (1) SI1922333T1 (cg-RX-API-DMAC7.html)
TW (1) TWI386416B (cg-RX-API-DMAC7.html)
WO (1) WO2007023163A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200801426B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2512525C2 (ru) * 2005-08-26 2014-04-10 Новозимс Эдениум Байотек А/С Полипептиды, обладающие антимикробной активновностью, и полинуклеотиды, кодирующие их
US20100227803A1 (en) * 2005-12-14 2010-09-09 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
EP2248893A1 (en) 2009-05-06 2010-11-10 Novozymes A/S DFPase Enzymes from Octopus Vulgaris
US8653024B2 (en) 2009-12-11 2014-02-18 Adenium Biotech Aps Use of AMPs for treatment of UTI/cystitis
EP2336155A1 (en) 2009-12-21 2011-06-22 Centre National de la Recherche Scientifique (CNRS) Antimicrobial peptides
US8835604B2 (en) * 2010-06-12 2014-09-16 Adenium Biotech Aos Antimicrobial peptide variants and polynucleotides encoding same
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
US8670119B1 (en) 2013-01-30 2014-03-11 Hewlett-Packard Development Company, L.P. Apparatus having surface-enhanced spectroscopy modules
CN106146629B (zh) * 2015-04-21 2020-03-31 中国农业科学院饲料研究所 一组胰蛋白酶抗性抗菌肽及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
DK0765394T3 (da) 1994-06-03 2001-12-10 Novozymes As Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse
EP1559776A3 (en) 1994-06-30 2006-01-11 Novozymes Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
DK1124949T3 (da) 1998-10-26 2006-11-06 Novozymes As Konstruktion og screening af et DNA-bibliotek af interesse i trådformede svampeceller
EP2278016B1 (en) 1999-03-22 2012-09-26 Novozymes Inc. Promoter sequences derived from Fusarium Venenatum and uses thereof
US6337317B1 (en) * 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
RU2261866C1 (ru) * 2004-02-10 2005-10-10 Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук ПЕПТИДЫ АРЕНИЦИНЫ, ВЫДЕЛЕННЫЕ ИЗ МОРСКОГО КОЛЬЧАТОГО ЧЕРВЯ ArenicolA marina, ОБЛАДАЮЩИЕ АНТИМИКРОБНЫМ ДЕЙСТВИЕМ
EP1863836B1 (en) * 2005-03-18 2012-07-11 Novozymes Adenium Biotech A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
US7534762B2 (en) * 2005-03-18 2009-05-19 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2007009978A1 (en) * 2005-07-15 2007-01-25 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
RU2512525C2 (ru) * 2005-08-26 2014-04-10 Новозимс Эдениум Байотек А/С Полипептиды, обладающие антимикробной активновностью, и полинуклеотиды, кодирующие их
US20100227803A1 (en) * 2005-12-14 2010-09-09 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
RU2316595C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения антимикробного пептида ареницина
RU2316590C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pE-His8-TrxL-Ar2, КОДИРУЮЩАЯ ГИБРИДНЫЙ БЕЛОК, СОДЕРЖАЩИЙ АНТИМИКРОБНЫЙ ПЕПТИД АРЕНИЦИН МОРСКОГО КОЛЬЧАТОГО ЧЕРВЯ Arenicola marina, И ШТАММ Escherichia coli BL21(DE3)/pE-His8-TrxL-Ar2 - ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА, СОДЕРЖАЩЕГО АРЕНИЦИН

Similar Documents

Publication Publication Date Title
JP2005533481A5 (cg-RX-API-DMAC7.html)
JP2006518372A5 (cg-RX-API-DMAC7.html)
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
JP2019524150A5 (cg-RX-API-DMAC7.html)
JP2015504675A5 (cg-RX-API-DMAC7.html)
JP2018520997A5 (cg-RX-API-DMAC7.html)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2004511201A5 (cg-RX-API-DMAC7.html)
JP2005102701A5 (cg-RX-API-DMAC7.html)
JP2018520646A5 (cg-RX-API-DMAC7.html)
JP2008508859A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
JP2014513952A5 (cg-RX-API-DMAC7.html)
JP2012515557A5 (cg-RX-API-DMAC7.html)
JP2018537089A5 (cg-RX-API-DMAC7.html)
JP2006502702A5 (cg-RX-API-DMAC7.html)
JP2004531242A5 (cg-RX-API-DMAC7.html)
JP2013531491A5 (cg-RX-API-DMAC7.html)
JP2019517262A5 (cg-RX-API-DMAC7.html)
JP2011505164A5 (cg-RX-API-DMAC7.html)
JP2009507474A5 (cg-RX-API-DMAC7.html)
JP2009509553A5 (cg-RX-API-DMAC7.html)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2020127419A5 (cg-RX-API-DMAC7.html)
JP2004537284A5 (cg-RX-API-DMAC7.html)